Lung cancer (Amsterdam, Netherlands)HumansMaleFemaleLung DiseasesInterstitial
Safety and outcomes of intensity modulated proton therapy in patients with non small cell lung cancer with interstitial lung disease.
Richard T Roden, William S Harmsen, William G Breen, Jenesse N Moffett, Sydney D Pulsipher, Kenneth R Olivier, Yolanda I Garces, Sean S Park, Kenneth W Merrell, Jann N Sarkaria, Dawn Owen
Published: 202510.1016/j.lungcan.2025.108789
Abstract
The treatment of non-small cell lung cancer (NSCLC) in interstitial lung disease (ILD) remains a challenging clinical scenario. These patients are often not good operative candidates due to poor lung function. Radiotherapy has emerged as a non-operat…
Preview only. Read the full abstract at the source